NILOTINIB TARTRATE | N219293 | AZURITY PHARMACEUTICALS INC
2 strengths4 unique patents0 unique exclusivities
Products (2)
Sort:
Patents (4)
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|
| 10874671 | Feb 18, 2040 | — | — | Yes | — | — |
| 11793809 | Feb 18, 2040 | — | — | Yes | — | — |
| 12403140 | Feb 18, 2040 | — | — | Yes | — | — |
| 12629369 | Feb 18, 2040 | — | — | Yes | — | — |
ADDED7/1/2026
Azurity added US Patent 12629369 to the Orange Book listing for Nilotinib Tartrate (Danziten), NDA 219293.
ADDED7/1/2026
Azurity added U.S. Patent 12,629,369 to the Orange Book listing for Nilotinib Tartrate (Danziten, NDA 219293).